Business Wire

MI-EATON-VEHICLE-GROUP

Share
Eaton’s Vehicle Group Facilities Reducing Environmental Impact With New Technologies and Systems

Power management company Eaton today announced its Vehicle Group has certified 88% of its global facilities as “zero-waste-to-landfill” (ZWTL), having cut the amount of waste going into landfills by 55% since 2019. Eaton defines ZWTL as consistently achieving a landfill waste diversion rate of 98% through reuse, composting, recycling or incineration, but only if the heat generated by incineration was collected and used to create more energy than what was used in the incineration process.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220421005050/en/

“We are extremely proud of how we’ve come together to upgrade our manufacturing facilities, leveraging technology to improve energy efficiency, minimize environmental impact and bring us closer to a carbon-free future,” said Sunil Bhandari, vice president, Global Operations, Eaton’s Vehicle Group. “Our commitment to sustainability is part of our core mission to improve the quality of life and the environment for those who count on us today and in the decades to come.”

To reduce waste, the Vehicle Group is focused on four primary areas: reuse, recycle, waste to energy and waste to landfill.

Separating swarf from water and recycling keeps it from landfill

One of the key projects in these efforts is the Vehicle Group’s swarf grinding project, which is in the process of being implemented at all its global sites that perform grinding operations.

Swarf is a byproduct generated during metal-cutting processes when fluids such as oils, coolants and water are mixed with fine particles of metal and filtration media. Swarf is one of the most difficult waste streams to recycle, but the Vehicle Group has made great strides in diverting swarf waste from landfills.

Through vendor partnerships, the Vehicle Group deploys a mobile centrifuge process that separates the materials. The fluid then is reused in manufacturing processes, and the metal particles are recycled, resulting in cost savings. A swarf recycling trial in 2019 diverted 500 tons from the landfill, and work is ongoing to expand this solution to expedite ZWTL progress.

The Vehicle Group is finding reuse opportunities to eliminate sludge created during the plating process by recycling the metal content, which eliminates the need for disposal into a landfill. It is also working to develop a more efficient filtering process to remove sludge and reuse the water for further plating.

Additionally, significant progress is being made in the segregation of general trash. Trash is typically created from a lack of knowledge of recycling opportunities and the use of unrecyclable materials. In an effort to prevent paper, metal and recyclable plastics from going into the trash, the Vehicle Group is working to improve education around recycling opportunities and procedures. Along these same lines, the Vehicle Group is ensuring all packaging it uses is recyclable and is encouraging its suppliers to do the same.

“For these efforts to realize their full potential, we are educating our teams on correct recycling methods, and we are asking for input on how to identify issues and new areas of opportunity,” Bhandari said.

Water conservation efforts making a significant impact at global sites

Implementing several innovative initiatives, the Vehicle Group has lowered water consumption at its global sites by 14% since 2019, putting it well on its way to achieving its 2030 zero water discharge target.

To reduce water consumption and mitigate pollutants, the Vehicle Group is installing wastewater systems featuring ultrafiltration and reverse osmosis technologies at several of its facilities. The systems treat and reuse water for industrial purposes. Some facilities are also managing stormwater by increasing the permeability of their property, decreasing runoff rates to reduce erosion and planting native florae that don’t require watering. Additionally, automatic flow-sensor faucets are being installed at Vehicle Group global facilities to enable the reuse of chiller water used during daily operations.

Read more about Eaton’s commitment to sustainability in its latest Sustainability Report.

Learn more about how Eaton is helping its customers conserve resources and reduce their carbon footprint.

Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power — today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and all of society.

Founded in 1911, Eaton has been listed on the NYSE for nearly a century. We reported revenues of $19.6 billion in 2021 and serve customers in more than 170 countries. For more information, visit www.eaton.com . Follow us on Twitter and LinkedIn.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press release

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable

GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press release

Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus

Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press release

Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye